🇺🇸 FDA

Intelligence · Clinical Pipeline

Infectious disease · Phase II

Infectious disease programs at Phase II — ClinicalTrials.gov pipeline intelligence.

Programs
375

Quick answer

Infectious disease Phase II programs: NovaPharmaNews indexes 375 matching clinical development programs from ClinicalTrials.gov with sponsor, modality, and NCT cross-links.

Top sponsors

Page 2 of 8

  1. BRII-179

    Vir Biotechnology

    For Treatment of Chronic Hepatitis B Virus Infection

    phase 2 mab active

    1 trial

  2. BRII-835 (VIR-2218)

    Vir Biotechnology

    Hepatitis B, Chronic

    phase 2 small molecule completed

    1 trial

  3. Bacteriophage

    Adaptive Biotechnologies Corp

    Prosthetic Joint Infection

    phase 2 small molecule terminated

    1 trial

  4. Bacteriophage Therapy

    Adaptive Biotechnologies Corp

    Urinary Tract Infection Bacterial

    phase 2 mab terminated

    1 trial

  5. Bamlanivimab

    Vir Biotechnology

    COVID-19

    phase 2 small molecule completed

    1 trial

  6. Behavior Therapy

    BRIGHT MINDS BIOSCIENCES INC.

    The Study Was Designed to Develop a Cognitive Behavioral Approach to Treating Methamphetamine Abuse in HIV Primary Care Settings

    phase 2 other terminated

    1 trial

  7. Behavioral Drug and Risk Counseling (BDRC)

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Risk Behaviors

    phase 2 other completed

    1 trial

  8. Bemnifosbuvir

    Atea Pharmaceuticals

    Chronic Hepatitis C Virus

    phase 2 small molecule completed

    1 trial

  9. Benznidazole

    BRIGHT MINDS BIOSCIENCES INC.

    Trypanosoma Cruzi Infection

    phase 2 small molecule completed

    1 trial

  10. Bisphosphocin Nu-3

    Lakewood-Amedex Biotherapeutics

    Diabetic Foot Infections

    phase 2 small molecule completed

    1 trial

  11. Bovine colostrum

    Hospital Authority, Hong Kong

    Severe Alcoholic Hepatitis in 'Extremis'- Defined by mDF>54

    phase 2 other completed

    1 trial

  12. Brincidofovir

    Jazz Pharmaceuticals Ireland Limited

    Cytomegalovirus Infection

    phase 2 small molecule completed

    1 trial

  13. Budigalimab, Placebo for Budigalimab (ABBV-181) - 0.9% Sodium Chloride or DILUENT, ABBV-382, Placebo for ABBV-382 Solution for Infusion

    AbbVie Deutschland GmbH & Co. KG

    HIV infection

    phase 2 small molecule active

    1 trial

  14. Buffer S9b Solution for suspension for injection

    GlaxoSmithKline

    Hepatitis B, Chronic

    phase 2 small molecule active

    1 trial

  15. Buffer S9b Solution for suspension for injection

    GlaxoSmithKline

    Hepatitis B, Chronic

    phase 2 small molecule active

    1 trial

  16. BufferGel

    BRIGHT MINDS BIOSCIENCES INC.

    HIV Infections

    phase 2 small molecule completed

    1 trial

  17. Busulfan Koanaa 6 mg/ml Konzentrat zur Herstellung einer Infusionslösung, GRANOCYTE 34 Millions UI/ml, poudre et solvant pour solution injectable / perfusion, Autologous CD34+ cells transduced with lentiviral vector encoding the human beta-globin gene, Plerixafor Accord 20 mg/ml solution for injection

    Fondazione Telethon ETS

    transfusion-dependent beta-thalassemia

    phase 2 small molecule active

    1 trial

  18. CAP-1002

    CAPRICOR THERAPEUTICS, INC.

    Covid19

    phase 2 mab completed

    1 trial

  19. CERC-002

    Avalo Therapeutics

    COVID-19 Pneumonia

    phase 2 small molecule completed

    1 trial

  20. CF 102

    Can-Fite BioPharma

    Chronic Hepatitis C

    phase 2 small molecule completed

    1 trial

  21. CF102

    Can-Fite BioPharma

    Non-alcoholic Steatohepatitis (NASH)

    phase 2 small molecule completed

    1 trial

  22. CHRONVAC-C®

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C Virus Infection

    phase 2 small molecule active

    1 trial

  23. COVAXIN(BBV152)

    Biotech Pharmaceutical Co.,

    Corona Virus Infection

    phase 2 mab completed

    1 trial

  24. COVID-19 Vaccine (Vero Cell), Inactivated (Medium-dose)

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab terminated

    1 trial

  25. COVID-19 Vaccine (Vero Cell), Inactivated, Omicron Strain

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  26. COVID-19 Vaccine HIPRA

    Hipra Human Health S.L.

    COVID-19

    phase 2 mab completed

    1 trial

  27. CP101

    Finch Therapeutics Group

    Clostridium Difficile Infection

    phase 2 mab completed

    1 trial

  28. CRV431 75mg

    Hepion Pharmaceuticals

    NASH - Nonalcoholic Steatohepatitis

    phase 2 small molecule completed

    1 trial

  29. CSG452 (Tofogliflozin) placebo, pemafibrate, K-877 ER (Pemafibrate) placebo, TOFOGLIFLOZIN

    The George Institute

    Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis

    phase 2 small molecule active

    1 trial

  30. CT-011

    Teva Pharma GmbH

    Chronic Hepatitis C

    phase 2 small molecule terminated

    1 trial

  31. CYSTAGON 150 mg hard capsules

    The George Institute

    Infectious diseases of respiratory system (COVID-19)

    phase 2 small molecule active

    1 trial

  32. Cefiderocol

    Shionogi B.V.

    Gram-negative Bacterial Infections

    phase 2 small molecule completed

    1 trial

  33. Ceftriaxone 1000mg + doxycycline 100 mg

    Hong Kong Baptist University

    Neisseria Gonorrhoeae Infection

    phase 2 small molecule completed

    1 trial

  34. Cemiplimab

    Regeneron UK Limited

    Hepatitis B Virus

    phase 2 mab terminated

    1 trial

  35. Cemiplimab

    Regeneron UK Limited

    HIV Infections

    phase 2 mab terminated

    1 trial

  36. ChAdOx1-HBV

    Barinthus Biotherapeutics plc.

    Chronic Hepatitis B

    phase 2 mab completed

    1 trial

  37. ChAdOx1-HBV

    Barinthus Biotherapeutics plc.

    Hepatitis B

    phase 2 mab completed

    2 trials

  38. ChAdOx1-HPV

    Barinthus Biotherapeutics plc.

    HPV Infection

    phase 2 mab completed

    1 trial

  39. Chidamide Combined with NKG2D CAR-NK Cell Therapy

    The First People's Hospital of Lianyungang

    HIV (Human Immunodeficiency Virus)

    phase 2 small molecule active

    1 trial

  40. Chinese Herb

    Chinese University of Hong Kong

    COVID-19

    phase 2 small molecule active

    1 trial

  41. Chlorid sodný B. Braun 0,9 % infuzní roztok, DUOFAG

    Lacuna Pharma Pty Ltd

    Surgical wound infection/dehiscence caused by S. aureus and/or P. aeruginosa colonization

    phase 2 small molecule active

    1 trial

  42. ChronVac-C + SOC

    INOVIO PHARMACEUTICALS, INC.

    Chronic Hepatitis C

    phase 2 small molecule active

    1 trial

  43. Comirnaty JN.1 30 micrograms/dose dispersion for injection COVID-19 mRNA Vaccine, LVT-001

    Tour Hekla

    Healthy volunteers

    phase 2 small molecule active

    1 trial

  44. Community Reinforcement Approach (CRA) + HIV prevention

    BRIGHT MINDS BIOSCIENCES INC.

    Substance Abuse

    phase 2 other completed

    1 trial

  45. Convalescent Plasma

    United Therapeutics Europe Ltd

    COVID-19

    phase 2 mab terminated

    1 trial

  46. Copegus

    Hoffmann-La Roche

    Hepatitis C, Chronic

    phase 2 small molecule completed

    1 trial

  47. CoronaVac®

    Sinovac Research and Development Co.,

    COVID-19

    phase 2 mab completed

    1 trial

  48. Cx611

    Takeda

    Bacterial Pneumonia

    phase 2 mab completed

    1 trial

Frequently asked questions

How many infectious disease Phase II programs exist?

375 programs match both the therapeutic area and stage filters in our published index.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.